Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FK506-binding protein 4 (FKBP52) is an immunophilin family member with peptidyl-prolyl cis-trans isomerase (PPIase) activity. It functions as a molecular chaperone, interacting with heat shock proteins (Hsp90 and Hsp70) and steroid hormone receptors, influencing protein folding, trafficking, and signaling pathways. It is implicated in neuroprotection and regulation of microtubule dynamics. Recent research suggests its potential as a biomarker and therapeutic target in Alzheimer's disease.
Peptidyl-prolyl cis-trans isomerase inhibition; co-chaperone activity impacting protein folding and stability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FK506-binding protein 4 (FKBP52).